首页/数据集/ShengqingJiangzhuoDecoction Restores the Immunotherapy Response by Reprogramming the IFN-γ/JAK-STAT1/PD-L1 Pathway in Hepatocellular Carcinoma（Supplementary Immunohistochemistry and Western Blot Data）

ShengqingJiangzhuoDecoction Restores the Immunotherapy Response by Reprogramming the IFN-γ/JAK-STAT1/PD-L1 Pathway in Hepatocellular Carcinoma（Supplementary Immunohistochemistry and Western Blot Data）

NIAID Data Ecosystem2026-05-10 收录

肝细胞癌免疫治疗

PD-L1表达分析

数据链接：

https://data.mendeley.com/datasets/hxckjj5d47 数据链接链接失效反馈

官方服务：

资源简介：

This section provides supplementary raw immunohistochemistry images and descriptions of the Western blot data.

应用场景：

创建时间：

2026-01-02

肝细胞癌免疫治疗

FASN抑制剂

The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment approach for hepatocellular carcinoma (HCC). However, patients with lowered major histocompatibility complex class I

DataCite Commons2024-05-21 更新140

Blocking CX3CR1+ Tumor-associated Macrophages Synergize with anti-PD-1 Therapy in Hepatocellular Carcinoma

肿瘤免疫微环境

肝细胞癌免疫治疗

The efficacy of immune checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC) treatment remains limited, warranting further investigation into the underlying mechanisms. Accumulating evidence i

NIAID Data Ecosystem40

Data and metadata supporting the article: PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma

犬类癌症免疫治疗

PD-L1表达分析

In the present study, canine Programmed death-ligand 1 (PD-L1) expression was assessed in various cancer types, using a new anti-PD-L1 mAb, 6C11-3A11, and the safety and efficacy of c4G12 were explore

Figshare2021-02-15 更新30

Expressions of PD-L1 on dog tumor cell lines.

犬骨肉瘤免疫治疗

PD-L1表达分析

The expression of PD-L1 was evaluated by flow cytometric analysis using anti-PD-L1 mAb 4G12-C1. -; 60% positive.*Cells were incubated with recombinant canine IFN-γ (100 ng/ml) for 24 h before the anal

Figshare2015-12-02 更新60

Supplementary Material for: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

肝细胞癌免疫治疗

生物标志物研究

Introduction: The prognostic nutritional index (PNI) is a multiparametric score introduced by Onodera based on the blood levels of lymphocytes and albumin in patients with gastrointestinal neoplasms.

Figshare2023-01-19 更新40

ShengqingJiangzhuoDecoction Restores the Immunotherapy Response by Reprogramming the IFN-γ/JAK-STAT1/PD-L1 Pathway in Hepatocellular Carcinoma（Supplementary Immunohistochemistry and Western Blot Data）

资源简介：

相关数据集